Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

Bezan A, Hohla F, Meissnitzer T, Greil R. BMC Cancer. 2013 Dec 31,13:618. doi: 10.1186/1471-2407-13-618.

Everolimus in postmenopausal, hormone receptor-positive advanced breast cancer: summary and results of an austrian expert panel discussion.

Gnant M, Greil R, Hubalek M, Steger G. Breast Care (Basel). 2013 Aug,8(4):293-9. doi: 10.1159/000354121. Review.

Influence of Body Mass Index on survival in indolent and Mantle-cell Lymphomas: Analysis of the StiL1 trial

Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Greil, R, Barth, J, Rummel, M ONKOLOGIE. 2013, 36: 31-32.

What’s new in Hodgkin’s lymphoma: ASH 2012 and more

Melchardt, T, Weiss, L, Greil, R, Egle, A, Magazine of European Medical Oncology. 2013, Volume 6, Issue 3: 193-196.

Viral infections and their management in patients with chronic lymphocytic leukemia.

Melchardt T, Weiss L, Greil R, Egle A. Leuk Lymphoma. 2013 Aug,54(8):1602-13. doi: 10.3109/10428194.2012.755178. Epub 2013 Jan 3.

Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.

Taylor N, Melchardt T, Grundbichler M, Strasser M, Egle A, Greil R. Ann Hematol. 2013 Jul,92(7):1001-2. doi: 10.1007/s00277-012-1659-z. Epub 2012 Dec 28.

Azacitidine in patients with WHO-defined AML – results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.

Pleyer L, Stauder R, Burgstaller S, Schreder M, Tinchon C, Pfeilstocker M, Steinkirchner S, Melchardt T, Mitrovic M, Girschikofsky M, Lang A, Krippl P, Sliwa T, Egle A, Linkesch W, Voskova D, Angermann H, Greil R. J Hematol Oncol. 2013 Apr 29,6:32. doi: 10.1186/1756-8722-6-32.

Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

Taylor N, Grabmeier-Pfistershammer K, Egle A, Greil R, Rieger A, Ledergerber B, Oberkofler H. PLoS One. 2013 Aug 30,8(8):e74024. doi: 10.1371/journal.pone.0074024. eCollection 2013.

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Melchardt T, Weiss L, Pleyer L, Steinkirchner S, Auberger J, Hopfinger G, Greil R, Egle A. Oncol Lett. 2013 Dec,6(6):1756-1758. Epub 2013 Oct 15.

CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.

Girbl T, Hinterseer E, Grössinger EM, Asslaber D, Oberascher K, Weiss L, Hauser-Kronberger C, Neureiter D, Kerschbaum H, Naor D, Alon R, Greil R, Hartmann TN. Cancer Res. 2013 Jan 15,73(2):561-70. doi: 10.1158/0008-5472.CAN-12-2749. Epub 2012 Nov 1.